Related Experiment Video
Updated: Jan 9, 2026
09:38
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
12.7K
Neuropalliative Care in Demyelinating Diseases.
Continuum (Minneapolis, Minn.)
|December 2, 2025
Summary
Neuropalliative care is crucial for managing symptoms and improving quality of life in patients with multiple sclerosis and other demyelinating diseases. Early integration into multidisciplinary teams enhances patient and caregiver support.
Area of Science:
- Neurology
- Palliative Care
Background:
- Disease-modifying therapies have improved outcomes for multiple sclerosis (MS).
- Palliative care is underutilized for persistent symptoms, caregiver burden, and psychosocial issues in MS.
- Demyelinating diseases present complex chronic care challenges.
Purpose of the Study:
- To explore the role of neuropalliative care in demyelinating diseases.
- To emphasize integration into multidisciplinary care for symptom relief and quality of life.
- To highlight the importance of early palliative care initiation.
Main Methods:
- Literature review on neuropalliative care in demyelinating diseases.
- Analysis of current multidisciplinary care models.
- Focus on symptom management, psychosocial support, and care partner burden.
Main Results:
- Neuropalliative care significantly enhances symptom management.
- Integration improves psychological support and quality of life.
- Early intervention benefits patients and care partners.
Conclusions:
- Neuropalliative care is essential for comprehensive management of MS and demyelinating diseases.
- An interdisciplinary approach integrating palliative care improves patient outcomes.
- Addressing psychosocial needs and care partner burden is vital.
Related Concept Videos
01:25Continuing Care
1.8K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.8K
01:15Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
01:27Peripheral Artery Disease III: Interprofessional Care
226
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
01:26Peripheral Artery Disease IV: Nursing Management
321
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
321
01:20Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
01:15Neurogenesis and Regeneration of Nervous Tissue
1.5K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.5K